We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$6.59B
AUM Growth
-$836M
Cap. Flow
-$1.17B
Cap. Flow %
-17.84%
Top 10 Hldgs %
15.06%
Holding
1,801
New
509
Increased
232
Reduced
294
Closed
676

Top Buys

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$18.4M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$15.6M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$15.4M
4
META icon
Meta Platforms (Facebook)
META
+$15M
5
ADBE icon
Adobe
ADBE
+$13.1M

Top Sells

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$23.1M
2
PANW icon
Palo Alto Networks
PANW
+$20.9M
3
CI icon
Cigna
CI
+$16.5M
4
CHTR icon
Charter Communications
CHTR
+$15.8M
5
CYTK icon
Cytokinetics
CYTK
+$12M

Sector Composition

Rank Sector Weight
1 Healthcare 2.73%
2 Communication Services 2.58%
3 Financials 2.16%
4 Technology 1.6%
5 Consumer Discretionary 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PODD icon
901
Insulet
PODD
$9.23B
$438K 0.01%
2,553
-47
-2% -$8.77K
PTON icon
902
PUT
Peloton Interactive
PTON
$2.82B
$437K 0.01%
101,900
-268,100
-72% -$1.32M
NLY icon
903
CALL
Annaly Capital Management
NLY
$17.1B
$431K 0.01%
21,900
– –
NTLA icon
904
Intellia Therapeutics
NTLA
$1.53B
$430K 0.01%
+15,616
New +$434K
DRVN icon
905
Driven Brands
DRVN
$2.41B
$426K 0.01%
+27,000
New +$374K
AMLX icon
906
PUT
Amylyx Pharmaceuticals
AMLX
$2.43B
$426K 0.01%
+150,000
New +$1.96M
GTHX
907
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$421K 0.01%
+97,568
New +$340K
RGNX icon
908
CALL
Regenxbio
RGNX
$672M
$421K 0.01%
20,000
-25,000
-56% -$445K
RGNX icon
909
PUT
Regenxbio
RGNX
$672M
$421K 0.01%
20,000
-25,000
-56% -$445K
ACM icon
910
Aecom
ACM
$9.63B
$412K 0.01%
+4,200
New +$380K
STER
911
PUT
DELISTED
Sterling Check Corp. Common Stock
STER
$402K 0.01%
+25,000
New +$357K
VOD icon
912
CALL
Vodafone
VOD
$35.4B
$401K 0.01%
+45,000
New +$391K
IBRX icon
913
ImmunityBio
IBRX
$7.59B
$396K 0.01%
+73,654
New +$334K
NTGR icon
914
CALL
NETGEAR
NTGR
$654M
$394K 0.01%
+25,000
New +$364K
PR
915
Permian Resources
PR
$16.6B
$394K 0.01%
22,300
+16,600
+291% +$244K
WBA
916
DELISTED
Walgreens Boots Alliance
WBA
$390K 0.01%
+18,000
New +$400K
HUBG icon
917
HUB Group
HUBG
$2.91B
$389K 0.01%
+9,000
New +$394K
GTHX
918
CALL
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$388K 0.01%
+89,700
New +$313K
APYX icon
919
CALL
Apyx Medical
APYX
$174M
$384K 0.01%
282,600
+268,700
+1,933% +$572K
PLAB icon
920
CALL
Photronics
PLAB
$1.89B
$382K 0.01%
+13,500
New +$402K
PLAB icon
921
PUT
Photronics
PLAB
$1.89B
$382K 0.01%
+13,500
New +$402K
CHWY icon
922
Chewy
CHWY
$9.84B
$382K 0.01%
+24,000
New +$431K
KSS icon
923
Kohl's
KSS
$2.23B
$379K 0.01%
+13,000
New +$349K
CORT icon
924
CALL
Corcept Therapeutics
CORT
$12B
$378K 0.01%
15,000
– –
OEC icon
925
Orion
OEC
$370M
$373K 0.01%
+15,838
New +$366K
35 36
37
38 39

Similar funds

ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Caption Management's Q1 2024 Portfolio in Review

As of Q1 2024, Caption Management held 1,801 positions worth $6.59B, down 11% from $7.42B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Caption Management withdrew a net $1.17B in Q1 2024, closing 676 positions and reducing 294 holdings. Its most notable exit was Palo Alto Networks, an estimated $20.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, up from 2.7% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Caption Management opened a new position in Adobe worth $11.5M.

  • Caption Management's largest Q1 2024 buy was Adobe: 22,800 shares worth $11.5M.
  • Caption Management added most to Sarepta Therapeutics in Q1 2024, an estimated $18.4M increase.
  • Caption Management's biggest Q1 2024 reduction was Apellis Pharmaceuticals, cutting an estimated $23.1M.
  • Caption Management fully exited Palo Alto Networks in Q1 2024, selling an estimated $20.9M.
  • Caption Management's ten largest holdings make up 15% of its $6.59B portfolio in Q1 2024.
  • Caption Management opened 509 new positions and closed 676 in Q1 2024.
  • Caption Management's portfolio value fell 11% quarter-over-quarter to $6.59B.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.